Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wells Fargo Analyst Upgrades Price Target for Chart Industries NYSE GTLS

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Investings on laptops and finances
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, Wells Fargo analyst Roger Read reiterated his positive stance on Chart Industries (NYSE: GTLS), upgrading the price target from $155 to $172. This comes after Wells Fargo initially covered the stock with an Overweight rating and a price target of $230, suggesting a potential upside of 14.3%. Furthermore, the price target was adjusted upward to $226 from $224 while maintaining the Overweight rating. These adjustments indicate Wells Fargo’s strong belief in Chart Industries’ performance and growth prospects.

Chart Industries, Inc. (GTLS) Stock Shows Positive Momentum on March 2, 2024

On March 2, 2024, Chart Industries, Inc. (GTLS) showed positive momentum in its stock performance. The stock closed at $146.58, which was $3.72 higher than the previous market close, representing a 2.60% increase. This upward movement is a promising sign for investors, indicating potential growth in the company’s value.

GTLS is currently trading in the middle of its 52-week range, suggesting that there is room for further price movements in either direction. Additionally, the stock is trading above its 200-day simple moving average, indicating a positive long-term trend in its price performance.

However, it is worth noting that GTLS experienced a slight drop of $0.58 in after-hours trading. While this drop may cause some concern among investors, it is important to consider that after-hours trading can be more volatile and may not always accurately reflect the stock’s overall performance. Investors should continue to monitor the stock’s movement and consider other factors such as market trends and company news to make informed investment decisions.

GTLS Stock Performance Analysis: Revenue and Net Income Increase, EPS Decrease – March 2, 2024

On March 2, 2024, GTLS stock had some interesting performances based on the financial data provided by CNN Money. The total revenue for the company was reported to be $3.35 billion for the past year and $1.01 billion for the last quarter.

Net income for GTLS was reported to be $47.70 million for the past year and $47.80 million for the last quarter.

Earnings per share (EPS) for GTLS were reported to be $0.44 for the past year and $0.98 for the last quarter.

Overall, the financial performance of GTLS on March 2, 2024, shows a mixed picture. While the company has seen significant growth in total revenue and net income, there are some concerns about the decrease in EPS. Investors will likely be keeping a close eye on future earnings reports to see if the company can continue its positive momentum and address any potential issues.

Tags: GTLS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Annexon Inc Receives Upgrade from JP Morgan and Positive Outlook for GBS Treatment

Finance_Banking (2)

Analyst Chris Parkinson from Wolfe Research Rates Element Solutions as Peer Perform

Healthcare-sector

Elevance Health Stands by 2024 Forecast with Strong Financial Results

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com